David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Ethics and International Affairs 24 (4):395-414 (2010)
In order to achieve more ethical global health outcomes, health policies must be driven by health priorities and should take into account broader health policy requirements, including the needs of specific national health systems. It is thus important to recognize that the division of interests in key policy areas are not necessarily between the priorities of rich and poor countries, but between (1) pharmaceutical industry interests and health policy interests, and (2) national industrial and trade policy interests and public health policies. In this article I will focus on two broad common interests for health policy officials. Both have become important in the context of current global negotiations relating to access to medicines; pandemic influenza; and public health, innovation, and intellectual property rights. These are (1) ensuring access, availability, and the safety of pharmaceuticals, and (2) ensuring that research-and-development efforts respond to public health needs. I argue that these issues are not solely the concern of developing countries because the diminishing national policy space for health in pharmaceutical policies presents a challenge to all governments, including rich ones
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
|Through your library||Configure|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Rivka Amado & Nevin M. Gewertz (2004). Intellectual Property and the Pharmaceutical Industry: A Moral Crossroads Between Health and Property. [REVIEW] Journal of Business Ethics 55 (3):295 - 308.
Nevin M. Gewertz & Rivka Amado (2004). Intellectual Property and the Pharmaceutical Industry: A Moral Crossroads Between Health and Property. [REVIEW] Journal of Business Ethics 55 (3):295 - 308.
Meri Koivusalo (2006). The Impact of Economic Globalisation on Health. Theoretical Medicine and Bioethics 27 (1):13-34.
Stephen John (2009). Why 'Health' is Not a Central Category for Public Health Policy. Journal of Applied Philosophy 26 (2):129-143.
J. Wilson (2011). Why It's Time to Stop Worrying About Paternalism in Health Policy. Public Health Ethics 4 (3):269-279.
Lawrence O. Gostin (2001). Health Information: Reconciling Personal Privacy with the Public Good of Human Health. [REVIEW] Health Care Analysis 9 (3):321-335.
Norman Daniels (2008). Just Health: Meeting Health Needs Fairly. Cambridge University Press.
Nicole Hassoun (2012). Global Health Impact: A Basis for Labeling and Licensing Campaigns? Developing World Bioethics 12 (3):121-134.
Madison Powers & Ruth Faden (2008). Social Justice: The Moral Foundations of Public Health and Health Policy. OUP USA.
B. M. Meier, K. N. Brugh & Y. Halima (2012). Conceptualizing a Human Right to Prevention in Global HIV/AIDS Policy. Public Health Ethics 5 (3):263-282.
Angus Dawson (2005). Risk Perceptions and Ethical Public Health Policy: MMR Vaccination in the UK. Poiesis and Praxis 3 (4):229-241.
Patricia J. Arnold & Terrie C. Reeves (2006). International Trade and Health Policy: Implications of the GATS for US Healthcare Reform. [REVIEW] Journal of Business Ethics 63 (4):313 - 332.
Sabina Gainotti, Nicola Moran, Carlo Petrini & Darren Shickle (2008). Ethical Models Underpinning Responses to Threats to Public Health: A Comparison of Approaches to Communicable Disease Control in Europe. Bioethics 22 (9):466-476.
Laura Anderko (2010). Achieving Health Equity on a Global Scale Through a Community-Based, Public Health Framework for Action. Journal of Law, Medicine and Ethics 38 (3):486-489.
Added to index2010-12-17
Total downloads12 ( #106,463 of 1,088,810 )
Recent downloads (6 months)1 ( #69,735 of 1,088,810 )
How can I increase my downloads?